Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
RECOMMEND
